RWA Wealth Partners LLC Has $1.87 Million Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

RWA Wealth Partners LLC cut its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 3.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,732 shares of the financial services provider’s stock after selling 560 shares during the period. RWA Wealth Partners LLC’s holdings in iShares Biotechnology ETF were worth $1,865,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in IBB. Prism Advisors Inc. bought a new stake in iShares Biotechnology ETF during the fourth quarter valued at about $210,000. Klingenstein Fields & Co. LP bought a new stake in iShares Biotechnology ETF during the 4th quarter worth about $216,000. Signaturefd LLC grew its holdings in shares of iShares Biotechnology ETF by 14.2% in the 4th quarter. Signaturefd LLC now owns 1,120 shares of the financial services provider’s stock valued at $152,000 after acquiring an additional 139 shares in the last quarter. Robbins Farley increased its position in shares of iShares Biotechnology ETF by 14.4% during the 4th quarter. Robbins Farley now owns 25,097 shares of the financial services provider’s stock worth $3,409,000 after purchasing an additional 3,158 shares during the last quarter. Finally, abrdn plc acquired a new stake in iShares Biotechnology ETF in the fourth quarter valued at $5,928,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 1.5 %

Shares of NASDAQ:IBB opened at $128.02 on Wednesday. iShares Biotechnology ETF has a 52-week low of $111.83 and a 52-week high of $141.16. The company has a 50-day simple moving average of $134.81 and a 200 day simple moving average of $129.75.

iShares Biotechnology ETF Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were given a dividend of $0.126 per share. The ex-dividend date was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.39%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.